Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap

Although great success has been obtained in the clinic, the current immune checkpoint inhibitors still face two challenging problems: low response rate and immune-related adverse effects (irAEs). Here we report the combination of immunogenic chemotherapy and locally expressed PD-L1 trap fusion prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wantong, Shen, Limei, Wang, Ying, Liu, Qi, Goodwin, Tyler J., Li, Jingjing, Dorosheva, Olekasandra, Liu, Tianzhou, Liu, Rihe, Huang, Leaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993831/
https://www.ncbi.nlm.nih.gov/pubmed/29884866
http://dx.doi.org/10.1038/s41467-018-04605-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993831/
https://www.ncbi.nlm.nih.gov/pubmed/29884866
http://dx.doi.org/10.1038/s41467-018-04605-x

Ejemplares similares